Corrigendum to "Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies" [J. Autoimmun. 126 (2022) 102774]
J Autoimmun. 2022 Feb:127:102797.
doi: 10.1016/j.jaut.2022.102797.
Epub 2022 Feb 9.
1 Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: [email protected].
2 Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
3 Osaka University Graduate School of Medicine, Osaka, Japan.
4 Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
5 Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
6 Osaka University Graduate School of Medicine, Osaka, Japan; Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
7 Osaka University Graduate School of Medicine, Osaka, Japan; Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan.
8 Graduate School of Medicine, Kyoto University, Kyoto, Japan.
9 Osaka University Graduate School of Medicine, Osaka, Japan; World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.
10 Osaka University Graduate School of Medicine, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan.
11 Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; World Premier International Immunology Frontier Research Center, Osaka University, Osaka, Japan.